DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE was reported 37098 times

These side effects are most commonly reported by patients taking DONEPEZIL HYDROCHLORIDE:

# Side effect Count
0 FALL 3158
1 DEATH 2177
2 CONFUSIONAL STATE 1994
3 DIZZINESS 1833
4 DIARRHOEA 1823
5 FATIGUE 1796
6 NAUSEA 1708
7 DRUG INEFFECTIVE 1647
8 HALLUCINATION 1605
9 ASTHENIA 1551
10 SOMNOLENCE 1377
11 VOMITING 1341
12 DECREASED APPETITE 1238
13 DRUG INTERACTION 1236
14 DYSPNOEA 1138
15 OFF LABEL USE 1125
16 DEMENTIA 1120
17 SYNCOPE 1095
18 HEADACHE 1088
19 URINARY TRACT INFECTION 1037
20 INSOMNIA 1026
21 GAIT DISTURBANCE 1025
22 BRADYCARDIA 1016
23 MALAISE 1001
24 CONDITION AGGRAVATED 959
25 PNEUMONIA 935
26 TREMOR 926
27 HYPOTENSION 836
28 DEHYDRATION 826
29 WEIGHT DECREASED 804
30 AGITATION 791
31 MEMORY IMPAIRMENT 791
32 PYREXIA 750
33 PAIN 679
34 LOSS OF CONSCIOUSNESS 671
35 CONSTIPATION 654
36 DEPRESSION 648
37 COUGH 637
38 ARTHRALGIA 635
39 BALANCE DISORDER 628
40 PRODUCT DOSE OMISSION ISSUE 620
41 COGNITIVE DISORDER 613
42 ANXIETY 604
43 PRURITUS 599
44 BLOOD PRESSURE INCREASED 562
45 SEPSIS 554
46 CEREBROVASCULAR ACCIDENT 548
47 AGGRESSION 544
48 DELIRIUM 542
49 ABDOMINAL PAIN 535
50 HYPERTENSION 533
51 ABDOMINAL PAIN UPPER 531
52 ANAEMIA 501
53 GASTROINTESTINAL HAEMORRHAGE 496
54 GENERAL PHYSICAL HEALTH DETERIORATION 491
55 RASH 491
56 DELUSION 488
57 HYPERHIDROSIS 481
58 PARKINSON^S DISEASE 479
59 DYSPHAGIA 478
60 ACUTE KIDNEY INJURY 474
61 ATRIAL FIBRILLATION 469
62 ALTERED STATE OF CONSCIOUSNESS 457
63 ABNORMAL BEHAVIOUR 456
64 BACK PAIN 447
65 FEELING ABNORMAL 447
66 RENAL FAILURE 436
67 HALLUCINATION, VISUAL 432
68 LETHARGY 425
69 CHILLS 417
70 TOXICITY TO VARIOUS AGENTS 415
71 MUSCLE SPASMS 412
72 DYSKINESIA 410
73 ELECTROCARDIOGRAM QT PROLONGED 402
74 TACHYCARDIA 398
75 SEIZURE 395
76 COMA 389
77 CARDIO-RESPIRATORY ARREST 382
78 DEMENTIA ALZHEIMER^S TYPE 379
79 CONTUSION 378
80 PERIPHERAL SWELLING 377
81 MUSCULAR WEAKNESS 376
82 URINARY INCONTINENCE 376
83 PAIN IN EXTREMITY 372
84 OVERDOSE 367
85 MYALGIA 365
86 OEDEMA PERIPHERAL 364
87 HAEMATEMESIS 361
88 CHEST PAIN 356
89 MOBILITY DECREASED 356
90 CONVULSION 352
91 DISORIENTATION 350
92 AMNESIA 339
93 DEPRESSED LEVEL OF CONSCIOUSNESS 335
94 ABDOMINAL DISCOMFORT 331
95 EYE PAIN 331
96 VISION BLURRED 330
97 HAEMORRHAGIC STROKE 318
98 HYPONATRAEMIA 317
99 BLOOD PRESSURE DECREASED 315
100 HAEMATURIA 314
101 PNEUMONIA ASPIRATION 314
102 SPEECH DISORDER 314
103 NIGHTMARE 307
104 PRODUCT USE IN UNAPPROVED INDICATION 304
105 MYOCARDIAL INFARCTION 300
106 BLINDNESS 299
107 UNRESPONSIVE TO STIMULI 292
108 PRESYNCOPE 290
109 HEAD DISCOMFORT 289
110 COVID-19 288
111 HOSPITALISATION 280
112 RESTLESSNESS 280
113 BLOOD GLUCOSE INCREASED 278
114 ASCITES 275
115 CARDIAC FAILURE CONGESTIVE 275
116 HYPERSOMNIA 275
117 HYPOKALAEMIA 275
118 RHABDOMYOLYSIS 274
119 TINNITUS 272
120 CHRONIC KIDNEY DISEASE 266
121 MENTAL STATUS CHANGES 266
122 DIPLOPIA 265
123 HAEMOGLOBIN DECREASED 265
124 COMPLETED SUICIDE 260
125 MEDICATION ERROR 259
126 CARDIAC ARREST 258
127 SINUS BRADYCARDIA 257
128 INCORRECT DOSE ADMINISTERED 250
129 OCULAR DISCOMFORT 247
130 WEIGHT INCREASED 247
131 ORTHOSTATIC HYPOTENSION 246
132 SLEEP DISORDER 246
133 CARDIAC FAILURE 244
134 HIP FRACTURE 244
135 PRODUCT USE ISSUE 242
136 CEREBRAL HAEMORRHAGE 241
137 AMAUROSIS FUGAX 235
138 RENAL IMPAIRMENT 235
139 GENERALISED OEDEMA 233
140 NEUROLEPTIC MALIGNANT SYNDROME 229
141 DRUG DOSE OMISSION 224
142 URINARY RETENTION 220
143 HEAD INJURY 219
144 MUSCLE RIGIDITY 216
145 PARKINSONISM 214
146 URINARY TRACT DISORDER 214
147 RENAL FAILURE ACUTE 207
148 RESPIRATORY FAILURE 205
149 APHASIA 204
150 NASOPHARYNGITIS 203
151 ABNORMAL DREAMS 200
152 SEDATION 200
153 DYSSTASIA 197
154 TRANSIENT ISCHAEMIC ATTACK 197
155 DYSARTHRIA 196
156 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 195
157 HYPOGLYCAEMIA 194
158 PLATELET COUNT DECREASED 194
159 ERYTHEMA 192
160 MUSCULOSKELETAL STIFFNESS 192
161 BLOOD CREATININE INCREASED 191
162 PHOTOPHOBIA 191
163 HEART RATE DECREASED 188
164 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 182
165 ADVERSE DRUG REACTION 181
166 WHITE BLOOD CELL COUNT DECREASED 181
167 PARANOIA 180
168 VISUAL IMPAIRMENT 178
169 ALOPECIA 177
170 HYPOPHAGIA 176
171 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 175
172 POLLAKIURIA 175
173 GASTROINTESTINAL DISORDER 173
174 PSYCHOTIC DISORDER 173
175 HYPOAESTHESIA 172
176 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 170
177 IRRITABILITY 169
178 RHINORRHOEA 167
179 CARDIAC DISORDER 166
180 CEREBRAL INFARCTION 166
181 DISEASE PROGRESSION 165
182 MANIA 164
183 INFECTION 163
184 ACCIDENTAL OVERDOSE 162
185 MULTIPLE SCLEROSIS RELAPSE 162
186 PARAESTHESIA 162
187 GAIT INABILITY 161
188 SUICIDAL IDEATION 159
189 UNDERDOSE 158
190 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 156
191 HAEMORRHAGE 156
192 DRUG HYPERSENSITIVITY 155
193 MOVEMENT DISORDER 155
194 OXYGEN SATURATION DECREASED 155
195 INCONTINENCE 153
196 ANGER 152
197 MELAENA 151
198 MYOCLONUS 150
199 PULMONARY EMBOLISM 150
200 ABDOMINAL DISTENSION 149
201 THROMBOCYTOPENIA 149
202 GASTROOESOPHAGEAL REFLUX DISEASE 148
203 PLEURAL EFFUSION 148
204 DEMENTIA ALZHEIMER'S TYPE 147
205 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 146
206 BRONCHITIS 146
207 DEVICE ISSUE 146
208 ENCEPHALOPATHY 146
209 HYPERKALAEMIA 146
210 HAEMATOMA 145
211 ILLNESS 145
212 INFLUENZA 144
213 BLOOD UREA INCREASED 141
214 DISTURBANCE IN ATTENTION 139
215 DYSURIA 139
216 EPILEPSY 139
217 PALPITATIONS 139
218 ARRHYTHMIA 138
219 PRODUCT DOSE OMISSION 138
220 RECTAL HAEMORRHAGE 138
221 THROMBOSIS 138
222 SUBDURAL HAEMATOMA 137
223 UNEVALUABLE EVENT 137
224 ATRIOVENTRICULAR BLOCK FIRST DEGREE 136
225 CIRCULATORY COLLAPSE 136
226 HAEMATOCHEZIA 136
227 INTERNATIONAL NORMALISED RATIO INCREASED 136
228 JOINT SWELLING 136
229 UPPER GASTROINTESTINAL HAEMORRHAGE 136
230 DRY MOUTH 135
231 DIABETES MELLITUS 133
232 EXTRAPYRAMIDAL DISORDER 132
233 PLEUROTHOTONUS 132
234 CELLULITIS 131
235 INFUSION RELATED REACTION 131
236 TREATMENT NONCOMPLIANCE 130
237 ANAL INCONTINENCE 128
238 DEPRESSED MOOD 128
239 DRUG INTOLERANCE 128
240 TORSADE DE POINTES 128
241 VERTIGO 127
242 DYSPEPSIA 126
243 EPISTAXIS 126
244 FLUSHING 126
245 MENTAL DISORDER 125
246 HEART RATE INCREASED 124
247 OEDEMA 124
248 SALIVARY HYPERSECRETION 123
249 ALANINE AMINOTRANSFERASE INCREASED 121
250 ASTHMA 121
251 CHEST DISCOMFORT 121
252 NEUROPATHY PERIPHERAL 121
253 ABASIA 120
254 LIVER FUNCTION TEST ABNORMAL 120
255 HOSPICE CARE 118
256 NEUTROPENIA 118
257 THERAPEUTIC RESPONSE UNEXPECTED 118
258 BRADYKINESIA 116
259 DEEP VEIN THROMBOSIS 116
260 DROOLING 114
261 CATARACT 113
262 CORONARY ARTERY DISEASE 113
263 HEPATIC FUNCTION ABNORMAL 113
264 ILL-DEFINED DISORDER 113
265 MULTIPLE SCLEROSIS 113
266 TARDIVE DYSKINESIA 113
267 THERAPY INTERRUPTED 113
268 INJURY 112
269 ASPARTATE AMINOTRANSFERASE INCREASED 111
270 HYPERGLYCAEMIA 111
271 PRESCRIBED UNDERDOSE 111
272 PSYCHOMOTOR HYPERACTIVITY 111
273 RIB FRACTURE 111
274 HYPERSENSITIVITY 110
275 HYPOTHERMIA 110
276 HYPOXIA 110
277 MENTAL IMPAIRMENT 110
278 OSTEOPOROSIS 110
279 BEDRIDDEN 109
280 NERVOUSNESS 109
281 SWELLING FACE 109
282 DYSPHONIA 108
283 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 108
284 PRODUCTIVE COUGH 108
285 WHITE BLOOD CELL COUNT INCREASED 108
286 ARTHRITIS 107
287 ATRIOVENTRICULAR BLOCK COMPLETE 106
288 BLOOD CREATINE PHOSPHOKINASE INCREASED 106
289 ANTICHOLINERGIC SYNDROME 105
290 BLOOD PRESSURE FLUCTUATION 105
291 CRYING 105
292 CYSTITIS 104
293 FEMUR FRACTURE 104
294 SINUSITIS 104
295 HOT FLUSH 103
296 INJECTION SITE PAIN 103
297 URTICARIA 103
298 WHEEZING 103
299 ASPIRATION 102
300 FRACTURE 101
301 NONSPECIFIC REACTION 101
302 FEMORAL NECK FRACTURE 100
303 MIGRAINE 100
304 MOTOR DYSFUNCTION 99
305 PALLOR 99
306 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99
307 EMOTIONAL DISTRESS 98
308 HYPOACUSIS 98
309 INTENTIONAL PRODUCT MISUSE 98
310 LIVER DISORDER 98
311 EATING DISORDER 97
312 GASTRIC ULCER 97
313 SUDDEN DEATH 97
314 FLATULENCE 96
315 MIOSIS 96
316 SWELLING 96
317 ADVERSE EVENT 95
318 CEREBRAL ATROPHY 95
319 FEELING HOT 95
320 RENAL DISORDER 95
321 VENTRICULAR TACHYCARDIA 95
322 DEVICE DISLOCATION 94
323 APATHY 93
324 NO ADVERSE EVENT 93
325 THERAPY CESSATION 93
326 CHOLINERGIC SYNDROME 92
327 DEMENTIA WITH LEWY BODIES 92
328 HALLUCINATION, AUDITORY 92
329 INFLUENZA LIKE ILLNESS 92
330 PULMONARY OEDEMA 92
331 DRY SKIN 91
332 DRUG LEVEL INCREASED 90
333 NECK PAIN 90
334 PANCYTOPENIA 90
335 STRESS 90
336 ANOREXIA 89
337 DISCOMFORT 89
338 ACUTE MYOCARDIAL INFARCTION 88
339 BLOOD GLUCOSE FLUCTUATION 88
340 INTENTIONAL OVERDOSE 88
341 COLD SWEAT 87
342 SEROTONIN SYNDROME 87
343 DECUBITUS ULCER 86
344 SUICIDE ATTEMPT 86
345 HIATUS HERNIA 85
346 INTERSTITIAL LUNG DISEASE 85
347 OSTEOARTHRITIS 85
348 BLISTER 83
349 CONTRAINDICATED PRODUCT ADMINISTERED 83
350 HYPOKINESIA 83
351 PRODUCT QUALITY ISSUE 83
352 ATRIOVENTRICULAR BLOCK 82
353 BLOOD POTASSIUM DECREASED 82
354 RED BLOOD CELL COUNT DECREASED 81
355 DISEASE RECURRENCE 79
356 DRUG-INDUCED LIVER INJURY 79
357 GENERALISED TONIC-CLONIC SEIZURE 79
358 TYPE 2 DIABETES MELLITUS 79
359 ATAXIA 78
360 GASTRITIS 78
361 HALLUCINATIONS, MIXED 78
362 LEUKOPENIA 78
363 NEPHROLITHIASIS 78
364 POOR QUALITY SLEEP 78
365 RASH PRURITIC 78
366 MUSCLE TWITCHING 77
367 C-REACTIVE PROTEIN INCREASED 76
368 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76
369 DYSPNOEA EXERTIONAL 76
370 FEEDING DISORDER 76
371 FLUID RETENTION 76
372 OROPHARYNGEAL PAIN 76
373 CHOKING 74
374 CHOLELITHIASIS 74
375 ECONOMIC PROBLEM 74
376 PANCREATITIS 74
377 ACTIVITIES OF DAILY LIVING IMPAIRED 73
378 DIVERTICULITIS 73
379 HERPES ZOSTER 73
380 SKIN EXFOLIATION 73
381 BURNING SENSATION 72
382 DEVICE OCCLUSION 72
383 DRUG ABUSE 72
384 HAEMATOCRIT DECREASED 72
385 INTENTIONAL PRODUCT USE ISSUE 72
386 SURGERY 72
387 COAGULOPATHY 71
388 BLOOD POTASSIUM INCREASED 70
389 DYSTONIA 70
390 HYPERNATRAEMIA 70
391 RESPIRATORY ARREST 70
392 FAECES DISCOLOURED 69
393 FEELING COLD 69
394 HEPATIC ENZYME INCREASED 69
395 LOWER GASTROINTESTINAL HAEMORRHAGE 69
396 PRODUCT PRESCRIBING ERROR 69
397 THERAPEUTIC RESPONSE SHORTENED 69
398 END STAGE RENAL DISEASE 68
399 HYPOTHYROIDISM 68
400 LUNG DISORDER 68
401 BLOOD GLUCOSE DECREASED 67
402 DEAFNESS 67
403 IMMOBILE 67
404 ROAD TRAFFIC ACCIDENT 67
405 BEHAVIOUR DISORDER 66
406 DRUG EFFECT DECREASED 66
407 MOOD ALTERED 66
408 MUSCULOSKELETAL PAIN 66
409 PELVIC FRACTURE 66
410 DIABETES MELLITUS INADEQUATE CONTROL 65
411 INITIAL INSOMNIA 65
412 SKIN DISCOLOURATION 65
413 SUBARACHNOID HAEMORRHAGE 65
414 THINKING ABNORMAL 65
415 WOUND 65
416 CARDIOMEGALY 64
417 EYE IRRITATION 64
418 PANIC ATTACK 64
419 POSTURE ABNORMAL 64
420 FREEZING PHENOMENON 63
421 HAEMORRHAGE INTRACRANIAL 63
422 METABOLIC ACIDOSIS 63
423 NOCTURIA 63
424 RESPIRATORY DISORDER 63
425 UPPER RESPIRATORY TRACT INFECTION 63
426 BODY HEIGHT DECREASED 62
427 DRUG DEPENDENCE 62
428 RENAL INJURY 62
429 STAPHYLOCOCCAL INFECTION 62
430 DRUG WITHDRAWAL SYNDROME 61
431 FAECAL INCONTINENCE 61
432 INCOHERENT 61
433 MALIGNANT NEOPLASM PROGRESSION 61
434 MULTIPLE DRUG THERAPY 61
435 STOMA SITE DISCHARGE 61
436 DRUG ADMINISTRATION ERROR 60
437 DUODENAL ULCER 60
438 FAILURE TO THRIVE 60
439 PERSONALITY CHANGE 60
440 SINUS NODE DYSFUNCTION 60
441 SKIN LACERATION 60
442 WITHDRAWAL SYNDROME 60
443 BLOOD CHOLESTEROL INCREASED 59
444 COORDINATION ABNORMAL 59
445 MICTURITION URGENCY 59
446 ON AND OFF PHENOMENON 59
447 PRODUCT DOSE OMISSION IN ERROR 59
448 RESPIRATORY DISTRESS 59
449 SEPTIC SHOCK 59
450 SLEEP APNOEA SYNDROME 59
451 SPINAL COMPRESSION FRACTURE 59
452 STUPOR 59
453 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59
454 ACUTE RESPIRATORY FAILURE 58
455 BLOOD ALKALINE PHOSPHATASE INCREASED 58
456 BLOOD SODIUM DECREASED 58
457 HEART RATE IRREGULAR 58
458 NEOPLASM MALIGNANT 58
459 SICK SINUS SYNDROME 58
460 COMMUNICATION DISORDER 57
461 LIVER FUNCTION TEST INCREASED 57
462 MOOD SWINGS 57
463 PRODUCT DISPENSING ERROR 57
464 SHOCK 57
465 TUBULOINTERSTITIAL NEPHRITIS 57
466 BLOOD GLUCOSE ABNORMAL 56
467 DIZZINESS POSTURAL 56
468 ERUCTATION 56
469 FEAR 56
470 GASTRIC DISORDER 56
471 GRAND MAL CONVULSION 56
472 INTENTIONAL DOSE OMISSION 56
473 ISCHAEMIC STROKE 56
474 LUNG NEOPLASM MALIGNANT 56
475 NIGHT SWEATS 56
476 OCULAR HYPERAEMIA 56
477 PRESCRIBED OVERDOSE 56
478 THERAPEUTIC RESPONSE DECREASED 56
479 COLITIS 55
480 DYSGEUSIA 55
481 FLUID INTAKE REDUCED 55
482 GASTROENTERITIS 55
483 HEMIPARESIS 55
484 PANCREATITIS ACUTE 55
485 SEDATION COMPLICATION 55
486 UPPER LIMB FRACTURE 55
487 AFFECT LABILITY 54
488 ANGIOEDEMA 54
489 BLOOD BILIRUBIN INCREASED 54
490 BONE PAIN 54
491 CATATONIA 54
492 LACTIC ACIDOSIS 54
493 LEUKOCYTOSIS 54
494 MULTIPLE ORGAN DYSFUNCTION SYNDROME 54
495 RESTLESS LEGS SYNDROME 54
496 RHEUMATOID ARTHRITIS 54
497 THERAPEUTIC PRODUCT EFFECT DECREASED 54
498 VASCULAR DEMENTIA 54
499 EMOTIONAL DISORDER 53
500 HYPOTONIA 53
501 INFLAMMATION 53
502 LIMB INJURY 53
503 MIDDLE INSOMNIA 53
504 SKIN LESION 53
505 ANKLE FRACTURE 52
506 BLOOD PRESSURE SYSTOLIC INCREASED 52
507 SOPOR 52
508 CHROMATURIA 51
509 RASH MACULAR 51
510 SCREAMING 51
511 STEVENS-JOHNSON SYNDROME 51
512 ARTHROPATHY 50
513 BRADYARRHYTHMIA 50
514 DRY EYE 50
515 GASTRIC ULCER HAEMORRHAGE 50
516 HAEMORRHAGIC ANAEMIA 50
517 JOINT INJURY 50
518 MALNUTRITION 50
519 PEMPHIGOID 50
520 PRODUCT SUBSTITUTION ISSUE 50
521 ACCIDENTAL EXPOSURE TO PRODUCT 49
522 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 49
523 LIP SWELLING 49
524 PLASMA CELL MYELOMA 49
525 REHABILITATION THERAPY 49
526 THERAPY NON-RESPONDER 49
527 ANHEDONIA 48
528 BLOOD PRESSURE ABNORMAL 48
529 HEPATITIS 48
530 INJECTION SITE ERYTHEMA 48
531 LABORATORY TEST ABNORMAL 48
532 NASAL CONGESTION 48
533 NEPHROGENIC ANAEMIA 48
534 OSTEONECROSIS OF JAW 48
535 RETCHING 48
536 DRUG ERUPTION 47
537 HYPERLIPIDAEMIA 47
538 LOWER RESPIRATORY TRACT INFECTION 47
539 PARKINSON'S DISEASE 47
540 TREATMENT FAILURE 47
541 ATRIOVENTRICULAR BLOCK SECOND DEGREE 46
542 BREAST CANCER 46
543 CARDIOVASCULAR DISORDER 46
544 FREQUENT BOWEL MOVEMENTS 46
545 HICCUPS 46
546 JAUNDICE 46
547 KIDNEY INFECTION 46
548 LIMB DISCOMFORT 46
549 WRIST FRACTURE 46
550 ARTERIOSCLEROSIS 45
551 GLAUCOMA 45
552 HAEMORRHOIDS 45
553 LACERATION 45
554 SPINAL FRACTURE 45
555 VIRAL INFECTION 45
556 ANGINA PECTORIS 44
557 DECREASED ACTIVITY 44
558 PROSTATE CANCER 44
559 RASH ERYTHEMATOUS 44
560 VISUAL ACUITY REDUCED 44
561 EXTRA DOSE ADMINISTERED 43
562 GASTRIC HAEMORRHAGE 43
563 LIBIDO INCREASED 43
564 OSTEOMYELITIS 43
565 PARALYSIS 43
566 SKIN ULCER 43
567 SOCIAL AVOIDANT BEHAVIOUR 43
568 UROSEPSIS 43
569 ATRIAL TACHYCARDIA 42
570 BLADDER DISORDER 42
571 BLOOD URINE PRESENT 42
572 DISSEMINATED INTRAVASCULAR COAGULATION 42
573 PRODUCT USE COMPLAINT 42
574 PULMONARY HYPERTENSION 42
575 VENTRICULAR EXTRASYSTOLES 42
576 DRUG EFFECT INCOMPLETE 41
577 ECZEMA 41
578 EYE DISORDER 41
579 GLYCOSYLATED HAEMOGLOBIN INCREASED 41
580 HYPERSEXUALITY 41
581 INCORRECT DRUG ADMINISTRATION DURATION 41
582 INTESTINAL HAEMORRHAGE 41
583 INTESTINAL OBSTRUCTION 41
584 IRON DEFICIENCY ANAEMIA 41
585 LACRIMATION INCREASED 41
586 LISTLESS 41
587 MITRAL VALVE INCOMPETENCE 41
588 REDUCED FACIAL EXPRESSION 41
589 RENAL FAILURE CHRONIC 41
590 TORTICOLLIS 41
591 DRUG DISPENSING ERROR 40
592 FEELING JITTERY 40
593 FUNGAL INFECTION 40
594 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40
595 INTERNAL HAEMORRHAGE 40
596 LOCALISED INFECTION 40
597 POTENTIATING DRUG INTERACTION 40
598 PRODUCT PRESCRIBING ISSUE 40
599 RESPIRATORY TRACT INFECTION 40
600 SKIN CANCER 40
601 SLOW SPEECH 40
602 SPINAL OSTEOARTHRITIS 40
603 BLOOD MAGNESIUM DECREASED 39
604 CLOSTRIDIUM DIFFICILE INFECTION 39
605 INCREASED APPETITE 39
606 MULTI-ORGAN FAILURE 39
607 PSORIASIS 39
608 BLOOD CREATINE INCREASED 38
609 BODY TEMPERATURE INCREASED 38
610 DECREASED INTEREST 38
611 ELECTROLYTE IMBALANCE 38
612 EYE MOVEMENT DISORDER 38
613 EYE PRURITUS 38
614 EYE SWELLING 38
615 INJECTION SITE BRUISING 38
616 LYMPHOCYTE COUNT DECREASED 38
617 MUSCLE SPASTICITY 38
618 THROAT IRRITATION 38
619 VENTRICULAR FIBRILLATION 38
620 CARDIAC PACEMAKER INSERTION 37
621 ELECTROCARDIOGRAM ABNORMAL 37
622 FACE OEDEMA 37
623 GASTRIC POLYPS 37
624 HAEMOPTYSIS 37
625 NEURODEGENERATIVE DISORDER 37
626 OSTEOPENIA 37
627 PHARMACEUTICAL PRODUCT COMPLAINT 37
628 RESPIRATORY DEPRESSION 37
629 SHOCK HAEMORRHAGIC 37
630 ABDOMINAL PAIN LOWER 36
631 AGEUSIA 36
632 ARTERIOSCLEROSIS CORONARY ARTERY 36
633 ATELECTASIS 36
634 BLOOD ALBUMIN DECREASED 36
635 CHOREA 36
636 HEPATIC CIRRHOSIS 36
637 INCORRECT PRODUCT ADMINISTRATION DURATION 36
638 LONG QT SYNDROME 36
639 MUSCULOSKELETAL DISORDER 36
640 NERVOUS SYSTEM DISORDER 36
641 PRODUCT ADMINISTRATION ERROR 36
642 SKIN DISORDER 36
643 TRICUSPID VALVE INCOMPETENCE 36
644 WALKING AID USER 36
645 APPLICATION SITE ERYTHEMA 35
646 BRAIN OEDEMA 35
647 CARDIOMYOPATHY 35
648 CROHN^S DISEASE 35
649 HYPERTONIA 35
650 HYPOMANIA 35
651 LYMPHADENOPATHY 35
652 MUSCLE CONTRACTIONS INVOLUNTARY 35
653 NEUROTOXICITY 35
654 RALES 35
655 RASH MACULO-PAPULAR 35
656 SUPRAVENTRICULAR EXTRASYSTOLES 35
657 AORTIC ANEURYSM 34
658 BLOOD LACTATE DEHYDROGENASE INCREASED 34
659 BUNDLE BRANCH BLOCK RIGHT 34
660 DERMATITIS ALLERGIC 34
661 DUODENAL ULCER HAEMORRHAGE 34
662 FEBRILE NEUTROPENIA 34
663 FULL BLOOD COUNT DECREASED 34
664 INTERVERTEBRAL DISC DEGENERATION 34
665 LEFT VENTRICULAR DYSFUNCTION 34
666 MACULAR DEGENERATION 34
667 RASH GENERALISED 34
668 RESPIRATORY RATE INCREASED 34
669 SCRATCH 34
670 SLUGGISHNESS 34
671 SPUTUM DISCOLOURED 34
672 SWOLLEN TONGUE 34
673 ABNORMAL LOSS OF WEIGHT 33
674 CONJUNCTIVITIS 33
675 DEVICE KINK 33
676 DEVICE LEAKAGE 33
677 EXPIRED PRODUCT ADMINISTERED 33
678 MUSCULOSKELETAL CHEST PAIN 33
679 ORAL PAIN 33
680 PERIPHERAL CIRCULATORY FAILURE 33
681 ROTATOR CUFF SYNDROME 33
682 TACHYPNOEA 33
683 TERMINAL STATE 33
684 APPLICATION SITE PRURITUS 32
685 BACK DISORDER 32
686 BENIGN PROSTATIC HYPERPLASIA 32
687 BODY TEMPERATURE DECREASED 32
688 DEVICE BREAKAGE 32
689 FACIAL PARALYSIS 32
690 FAECALOMA 32
691 HYPOVOLAEMIA 32
692 OSTEONECROSIS 32
693 PERICARDIAL EFFUSION 32
694 PERIPHERAL COLDNESS 32
695 PETIT MAL EPILEPSY 32
696 PNEUMONIA BACTERIAL 32
697 PROSTATIC SPECIFIC ANTIGEN INCREASED 32
698 RASH PAPULAR 32
699 SLEEP TERROR 32
700 STATUS EPILEPTICUS 32
701 STOMA SITE HAEMORRHAGE 32
702 CARDIAC FAILURE ACUTE 31
703 CHOLECYSTITIS 31
704 DIABETIC KETOACIDOSIS 31
705 DIVERTICULUM 31
706 DRUG RESISTANCE 31
707 ESSENTIAL HYPERTENSION 31
708 HEPATIC FAILURE 31
709 INFUSION SITE ERYTHEMA 31
710 INJECTION SITE HAEMORRHAGE 31
711 INTERVERTEBRAL DISC PROTRUSION 31
712 KNEE ARTHROPLASTY 31
713 LACUNAR INFARCTION 31
714 LOWER LIMB FRACTURE 31
715 NEUROGLYCOPENIA 31
716 NEUTROPHIL COUNT DECREASED 31
717 PERITONITIS 31
718 PNEUMONITIS 31
719 PULMONARY FIBROSIS 31
720 REFUSAL OF TREATMENT BY PATIENT 31
721 STOMATITIS 31
722 THERAPEUTIC AGENT TOXICITY 31
723 AGRANULOCYTOSIS 30
724 AORTIC STENOSIS 30
725 BLOOD CALCIUM DECREASED 30
726 BLOOD CHOLESTEROL DECREASED 30
727 CEREBRAL ISCHAEMIA 30
728 COLITIS MICROSCOPIC 30
729 DEVICE MALFUNCTION 30
730 DEVICE USE ISSUE 30
731 ELECTROCARDIOGRAM PR PROLONGATION 30
732 HYPOCALCAEMIA 30
733 LIVER INJURY 30
734 SECRETION DISCHARGE 30
735 SINUS ARREST 30
736 SUSPECTED SUICIDE 30
737 AKATHISIA 29
738 ATRIAL FLUTTER 29
739 BRAIN FOG 29
740 BUNDLE BRANCH BLOCK LEFT 29
741 CEREBRAL DISORDER 29
742 COVID-19 PNEUMONIA 29
743 CYANOSIS 29
744 DROPPED HEAD SYNDROME 29
745 DRUG PRESCRIBING ERROR 29
746 FOOT FRACTURE 29
747 LOCAL SWELLING 29
748 PETECHIAE 29
749 PRODUCT STORAGE ERROR 29
750 PYELONEPHRITIS 29
751 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29
752 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 28
753 BLOOD TRIGLYCERIDES INCREASED 28
754 CLOSTRIDIUM DIFFICILE COLITIS 28
755 CONCOMITANT DISEASE AGGRAVATED 28
756 DUODENAL ULCER PERFORATION 28
757 ERYTHEMA MULTIFORME 28
758 EUPHORIC MOOD 28
759 HYDROCEPHALUS 28
760 HYPERPARATHYROIDISM SECONDARY 28
761 ILEUS 28
762 INFUSION SITE PAIN 28
763 INFUSION SITE SWELLING 28
764 LABELLED DRUG-DRUG INTERACTION ISSUE 28
765 METABOLIC ENCEPHALOPATHY 28
766 MUSCLE ATROPHY 28
767 MUSCLE TIGHTNESS 28
768 MYOCARDIAL ISCHAEMIA 28
769 NO THERAPEUTIC RESPONSE 28
770 PAIN OF SKIN 28
771 PRURITUS GENERALISED 28
772 PULMONARY THROMBOSIS 28
773 RENAL CYST 28
774 SOMNAMBULISM 28
775 THYROID DISORDER 28
776 URINE OUTPUT DECREASED 28
777 WHEELCHAIR USER 28
778 ANOSMIA 27
779 COMPRESSION FRACTURE 27
780 DERMATITIS BULLOUS 27
781 DEVICE DIFFICULT TO USE 27
782 EYELID OEDEMA 27
783 FACIAL PAIN 27
784 GASTROINTESTINAL INFECTION 27
785 GLOMERULAR FILTRATION RATE DECREASED 27
786 HYPOMAGNESAEMIA 27
787 INTENTIONAL UNDERDOSE 27
788 LIVING IN RESIDENTIAL INSTITUTION 27
789 MUSCULOSKELETAL DISCOMFORT 27
790 NEUTROPHIL COUNT INCREASED 27
791 OBESITY 27
792 OESOPHAGITIS 27
793 PULMONARY MASS 27
794 SKIN ABRASION 27
795 SLEEP TALKING 27
796 STARING 27
797 WOUND INFECTION 27
798 AORTIC VALVE INCOMPETENCE 26
799 AUTONOMIC NERVOUS SYSTEM IMBALANCE 26
800 BLOOD COUNT ABNORMAL 26
801 CARDIAC MURMUR 26
802 CAROTID ARTERY STENOSIS 26
803 DYSGRAPHIA 26
804 EMPHYSEMA 26
805 EXTRASYSTOLES 26
806 GASTRIC CANCER 26
807 HEMIPLEGIA 26
808 IMPAIRED HEALING 26
809 INTENTIONAL DRUG MISUSE 26
810 LIPASE INCREASED 26
811 LOGORRHOEA 26
812 MAJOR DEPRESSION 26
813 OBSTRUCTIVE AIRWAYS DISORDER 26
814 OESOPHAGEAL ULCER 26
815 PARADOXICAL DRUG REACTION 26
816 SEXUALLY INAPPROPRIATE BEHAVIOUR 26
817 STOMA SITE ERYTHEMA 26
818 TOXIC EPIDERMAL NECROLYSIS 26
819 ANAPHYLACTIC REACTION 25
820 BONE DISORDER 25
821 CARDIOGENIC SHOCK 25
822 CEREBRAL HAEMATOMA 25
823 COMA SCALE ABNORMAL 25
824 CONCUSSION 25
825 CORONARY ARTERY OCCLUSION 25
826 DEPRESSIVE SYMPTOM 25
827 DIALYSIS 25
828 DIFFICULTY IN WALKING 25
829 DIVERTICULUM INTESTINAL 25
830 DYSPHEMIA 25
831 EMBOLIC STROKE 25
832 FACE INJURY 25
833 FOREIGN BODY 25
834 GASTROENTERITIS VIRAL 25
835 GOUT 25
836 HEPATITIS ACUTE 25
837 HERNIA 25
838 HYPERCHOLESTEROLAEMIA 25
839 INCORRECT ROUTE OF DRUG ADMINISTRATION 25
840 JOINT DISLOCATION 25
841 NEURALGIA 25
842 PANCREATIC CARCINOMA 25
843 PRODUCT DISTRIBUTION ISSUE 25
844 PROTHROMBIN TIME PROLONGED 25
845 SCAB 25
846 SEASONAL ALLERGY 25
847 SPINAL COLUMN STENOSIS 25
848 SPINAL OPERATION 25
849 STOMA SITE PAIN 25
850 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 25
851 VITAMIN D DEFICIENCY 25
852 ACUTE HEPATIC FAILURE 24
853 BACTERIAL INFECTION 24
854 BASAL CELL CARCINOMA 24
855 CENTRAL NERVOUS SYSTEM LESION 24
856 CHOLESTASIS 24
857 DRUG EFFECT LESS THAN EXPECTED 24
858 EJECTION FRACTION DECREASED 24
859 ENERGY INCREASED 24
860 EYELID PTOSIS 24
861 FOOT DEFORMITY 24
862 GRANULOCYTOPENIA 24
863 HYPERAMMONAEMIA 24
864 HYPERCALCAEMIA 24
865 HYPERTHYROIDISM 24
866 IMPAIRED QUALITY OF LIFE 24
867 LUNG INFECTION 24
868 PERIPHERAL VASCULAR DISORDER 24
869 PNEUMOTHORAX 24
870 PROSTATOMEGALY 24
871 SKIN HAEMORRHAGE 24
872 SPLENOMEGALY 24
873 SQUAMOUS CELL CARCINOMA 24
874 THIRST 24
875 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 24
876 BACK INJURY 23
877 CARDIAC FAILURE CHRONIC 23
878 DEFAECATION URGENCY 23
879 DIABETIC HYPEROSMOLAR COMA 23
880 HIP ARTHROPLASTY 23
881 IMPAIRED GASTRIC EMPTYING 23
882 MYDRIASIS 23
883 PEPTIC ULCER 23
884 PORIOMANIA 23
885 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 23
886 SCIATICA 23
887 STOMA SITE INFECTION 23
888 SUPRAVENTRICULAR TACHYCARDIA 23
889 TRANSAMINASES INCREASED 23
890 ANGIOPATHY 22
891 BIPOLAR DISORDER 22
892 BLOOD IRON DECREASED 22
893 BLOOD TEST ABNORMAL 22
894 BRONCHOSPASM 22
895 CAROTID ARTERY OCCLUSION 22
896 CARPAL TUNNEL SYNDROME 22
897 CEREBROVASCULAR DISORDER 22
898 COLON CANCER 22
899 COMPLICATION ASSOCIATED WITH DEVICE 22
900 DERMATITIS CONTACT 22
901 DEVICE USE ERROR 22
902 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22
903 DRUG TOXICITY 22
904 EAR PAIN 22
905 ELECTROENCEPHALOGRAM ABNORMAL 22
906 FOAMING AT MOUTH 22
907 GALLBLADDER DISORDER 22
908 HEPATIC ENCEPHALOPATHY 22
909 HUMERUS FRACTURE 22
910 HYPERTENSIVE CRISIS 22
911 HYPORESPONSIVE TO STIMULI 22
912 INABILITY TO AFFORD MEDICATION 22
913 LUMBAR VERTEBRAL FRACTURE 22
914 LUNG INFILTRATION 22
915 NEOPLASM PROGRESSION 22
916 PLATELET COUNT INCREASED 22
917 POST PROCEDURAL COMPLICATION 22
918 PRODUCT AVAILABILITY ISSUE 22
919 SIALOADENITIS 22
920 SMALL INTESTINAL OBSTRUCTION 22
921 THROAT TIGHTNESS 22
922 TOOTH LOSS 22
923 TOXIC ENCEPHALOPATHY 22
924 TRANSFUSION 22
925 VASCULITIS 22
926 AFFECTIVE DISORDER 21
927 AKINESIA 21
928 ANAPHYLACTIC SHOCK 21
929 BONE DENSITY DECREASED 21
930 BRAIN INJURY 21
931 ECCHYMOSIS 21
932 ELECTROCARDIOGRAM T WAVE INVERSION 21
933 EYE HAEMORRHAGE 21
934 FRUSTRATION 21
935 HEPATIC STEATOSIS 21
936 ILEUS PARALYTIC 21
937 INCREASED TENDENCY TO BRUISE 21
938 INJECTION SITE SWELLING 21
939 INSURANCE ISSUE 21
940 IRON DEFICIENCY 21
941 LYMPHOMA 21
942 MULTIPLE INJURIES 21
943 MYELODYSPLASTIC SYNDROME 21
944 OLIGURIA 21
945 ORAL CANDIDIASIS 21
946 PAIN IN JAW 21
947 PERICARDITIS 21
948 POLYDIPSIA 21
949 PROTEIN TOTAL DECREASED 21
950 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 21
951 SARS-COV-2 TEST POSITIVE 21
952 SINUS TACHYCARDIA 21
953 TASTE DISORDER 21
954 TOOTH EXTRACTION 21
955 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20
956 ACUTE CORONARY SYNDROME 20
957 BLOOD PRESSURE DIASTOLIC DECREASED 20
958 BLOOD SODIUM INCREASED 20
959 CYTOLYTIC HEPATITIS 20
960 EOSINOPHILIA 20
961 FIBROMYALGIA 20
962 HEPATOTOXICITY 20
963 HYPERTHERMIA 20
964 HYPERTONIC BLADDER 20
965 IMPAIRED DRIVING ABILITY 20
966 IMPULSIVE BEHAVIOUR 20
967 JOINT STIFFNESS 20
968 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20
969 LARGE INTESTINE POLYP 20
970 LEFT VENTRICULAR HYPERTROPHY 20
971 LUMBAR SPINAL STENOSIS 20
972 ORAL INTAKE REDUCED 20
973 PARTIAL SEIZURES 20
974 PERSECUTORY DELUSION 20
975 PRODUCT PHYSICAL ISSUE 20
976 PULMONARY CONGESTION 20
977 QUALITY OF LIFE DECREASED 20
978 SCOLIOSIS 20
979 SENSORY DISTURBANCE 20
980 SYSTEMIC LUPUS ERYTHEMATOSUS 20
981 TENSION HEADACHE 20
982 THERAPY CHANGE 20
983 ULCER 20
984 VITAMIN D DECREASED 20
985 APRAXIA 19
986 BRONCHOPNEUMONIA 19
987 CEREBELLAR HAEMORRHAGE 19
988 CERVICAL VERTEBRAL FRACTURE 19
989 DEVICE FAILURE 19
990 ESCHERICHIA URINARY TRACT INFECTION 19
991 FULL BLOOD COUNT ABNORMAL 19
992 HEPATOMEGALY 19
993 HOMICIDAL IDEATION 19
994 HYPERVENTILATION 19
995 HYPOALBUMINAEMIA 19
996 IMPAIRED SELF-CARE 19
997 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19
998 LYMPHOPENIA 19
999 MALIGNANT MELANOMA 19